icon-folder.gif   Conference Reports for NATAP  
 
  The Liver Meeting
AASLD 2024
Nov 15-19,
San Diego, CA
Back grey_arrow_rt.gif
 
 
 
LONG TERM OUTCOME AMONG HCV-INFECTED PEOPLE WHO USE DRUGS (PWUD) SUCCESSFULLY TREATED FOR HCV INFECTION WITH GLECAPREVIR/PIBRENTASVIR (G/P)
 
 
  S. YI,1 C. WIESMANN,1,2 D. TRUONG,1 and B. CONWAY1,2
 
1. Vancouver Infectious Diseases Centre, Vancouver, Canada
2. Faculty of Health Sciences, Simon Fraser University, Burnaby, Canada

1125241

1125242

1125243

1125244

1125245